Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic Fibrosis

NCT07569419 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis (CF)

Interventions

DRUG: Linaclotide 290 micrograms
DRUG: Lactose placebo pill

Sponsor

University of Nottingham